Through immunohistochemistry (IHC), it is possible to differentiate four main BC subtypes based on the expression of hormone receptors (HR) (such as estrogen receptors [ER] and progesterone receptors [PR]) and the human epidermal growth factor receptor 2 (HER2). Here, HR is linked to breast cancer.